Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC-MS/MS.
Mengming XiaXueyi SongZebei LuYu WangQuan ZhouPeiwu GengShuanghu WangYunfang ZhouQingjun WuAixia HanPublished in: Thoracic cancer (2023)
It is imperative to acknowledge the potential drug-drug interactions mediated by CYP3A4 between azoles and lenvatinib, as these interactions hold significant implications for their clinical utilization.
Keyphrases